KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $66,349,000 | +14.2% | 640,000 | -13.5% | 2.03% | +6.7% |
| Q1 2017 | $58,083,000 | +61.9% | 740,000 | -7.5% | 1.90% | +43.0% |
| Q4 2016 | $35,872,000 | -19.7% | 800,000 | 0.0% | 1.33% | -15.4% |
| Q3 2016 | $44,688,000 | +19.2% | 800,000 | +6.7% | 1.57% | +6.1% |
| Q2 2016 | $37,500,000 | +8.9% | 750,000 | 0.0% | 1.48% | +8.2% |
| Q1 2016 | $34,433,000 | -25.5% | 750,000 | 0.0% | 1.37% | +5.1% |
| Q4 2015 | $46,215,000 | +10.7% | 750,000 | 0.0% | 1.30% | -1.7% |
| Q3 2015 | $41,760,000 | +95.7% | 750,000 | +114.3% | 1.32% | +129.1% |
| Q2 2015 | $21,340,000 | – | 350,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|